UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $259,000 | +0.8% | 13,800 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $257,000 | +3.2% | 13,800 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $249,000 | -12.9% | 13,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $286,000 | -34.3% | 13,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $435,000 | +1015.4% | 13,800 | +1177.8% | 0.00% | – |
| Q4 2020 | $39,000 | -2.5% | 1,080 | 0.0% | 0.00% | – |
| Q3 2020 | $40,000 | -67.2% | 1,080 | -60.1% | 0.00% | – |
| Q2 2020 | $122,000 | -4.7% | 2,705 | 0.0% | 0.00% | – |
| Q1 2020 | $128,000 | -68.2% | 2,705 | -51.7% | 0.00% | -100.0% |
| Q4 2019 | $402,000 | – | 5,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |